Top 13 MNC Pharma Companies in India

List of MNC Pharma Companies in India – The Indian Pharmaceutical market (IPM) accounts for approx. 3% of the global pharmaceutical industry in value terms and 20% in volume terms. Indian pharmaceutical market is the world’s largest supplier of generic drugs, accounting for 20% of global export volume. Owing to robust historical growth, many MNC pharma companies have an active presence in the Indian pharma space. My blog gives you conclusive data about some of the top 10 Multinational Pharma Franchise Companies in India.
Besides the domestic market, Indian pharma companies also have a large chunk of their revenues coming from exports. Major companies have revenues coming in from the sale of intermediates, active pharmaceutical ingredients (APIs), and formulations in various global markets. These include developed markets like the US, Europe, and Japan and semi-developed markets across the world. Some companies also derive revenues by providing custom research and manufacturing services to innovator companies.
India accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s leader in Drug Master Files (DMFs) applications with the US Indian Drugs and pharmaceuticals sector receiving cumulative FDI worth US$ 15.83 billion. India is the preferred nation for pharmaceutical generation, with low charges for research and development as well as the production of drugs. And the pharmaceutical companies in India have made full use of the favorable environment offered by the country to make it big.
List of Top 10 MNC Pharma Companies in India
Top 10 MNC Pharma Companies in India recognized the potential of the Indian pharmaceutical market and showed interest in setting up manufacturing plants in India. Because of MNC companies Indian pharma students get a lot of opportunities to be exposed to international standard salaries and growth opportunities. Below is a list of top MNC Pharma Companies in India. These company shares are actively traded on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) of India.
- Biotic Healthcare
- USV Private Limited
- Serdia Pharmaceuticals (India) Pvt. Ltd
- AMN Life
- Harson Laboratories
- Tuttsan Pharma Pvt. Ltd
- Wockhardt
- Marksans Pharma Ltd
- Divi’s Laboratories
- Orchid Chemicals & Pharmaceuticals Ltd
1. Biotic Healthcare:
As a WHO & GMP certified MNC Pharma Companies in India, Biotic Healthcare comes with Rich pharmaceutical expertise & deals in various therapeutics like Antibiotics and antimicrobials, βlactams, Analgesics and anti-inflammatory, Antiulcerents, Antacids, Expectorants & Anti-Tussives, Neutraceuticals, Anti-Allergic, Skincare, Ointments, Injectables, Ear, Eye drops and a huge range of Herbal Products. Their R&D team is focused on finding innovative therapies for the human race.
Biotic Healthcare is an ISO 9001:2008 Certified Pharmaceutical Company & has been getting its manufacturing from WHO & GMP certified facilities for offering reasonably priced medicines in this predominantly multinational-dominated environment. They have tied up with GMP Certified Companies with world-class manufacturing facilities at Excise Free Zones in Himachal Pradesh. This company provides them with the best possible quality for their products. The company is one of the leading MNC Pharma Companies in India. Their offered product list includes:
- ORTH-1 Tablets
- SeraTic-DP Tablets
- Taver-M Tablets
- TicFe Plus Capsules
- PPiZOLE-DSR Capsules
- RanZole-DM Capsules
- Nazotic Nasal Spray
- Becotic Pediatric Drops
- Hony Cure- Tulsi Honey
- Sertox – Sertaconazole Nitrate Cream
- Fusiact – Fusidic Acid Cream IP
- Macsone – Mometasone Furocate Cream IP
- Dicloace Gel etc.
Established Year | 2014 |
GST No. | 06AAGCB4867M1Z7 |
Drug License | Yes |
Product Range | NA |
Major Categories | Derma products, Pharmaceutical tablets, Capsules, liquids, drops, and creams or ointments. |
Total No. of Employees | 11–50 |
Managing Director | Sunil Thakral, Rani Garg, Suresh Garg, Yashna Garg and Rahul Thakral. |
Contact them – Level 1, SCO-25, MDC, Swastik Vihar, Sector 5, Panchkula, Haryana 134109
2. USV Private Limited:
The company is a 55-year-old one of the leading MNC Pharma Companies in India which began as a joint venture with USV&P Inc. The USA, a subsidiary of Revlon. Their product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed dosage formulations (FDF), Peptides, Biosimilars, and Injectables. These are manufactured in their cGMP-compliant plants located in India. Their spending of 6.1% of sales on R&D ensures that they are able to deliver on their research portfolio.
They have over 100,000 sq. ft. of laboratory space with excellent infrastructure. In India, they are recognized for their leadership in the Oral Anti-Diabetic market where they rank No. 1 by Rx and Value. In the Cardiovascular diseases segment, they are No. 1 by Rx and rank no. 6 by Value. The company also has a significant presence in the areas of Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology, and CNS. Their offered product list includes:
- Metformin HCL BP/Ph.Eur/JP/USP
- Glibenclamide BP/Ph.Eur /Glyburide USP
- Atovaquone USP (Form – I and III)
- Clopidogrel Bisulphate USP (Form – I)
- Dolasetron Mesylate USP
- Eptifibatide Injection 20mg/10 ml & 75mg/100 ml (Anti-Thrombotic Agent)
- Bivalirudin Injection 250 mg lyophilized powder in a 10ml vial (Anti-Thrombotic Agent)
- Zoledronic Acid Injection 4mg/5 ml liquid concentrate
- Teriparatide Injection 750 mcg in 3 ml (Parathyroid Hormone)
- Latanoprost 50 mcg/ml Ophthalmic Solution (Prostaglandin)
- Olopatadine HCl 0.1 %Ophthalmic Solution
- Octreotide (Somatostatin, Growth hormone inhibitor)
Established Year | 1961 |
GST No. | 23AAACU1366N1Z8 |
Drug License | Yes |
Product Range | 50 |
Major Categories | Active pharmaceutical ingredients (APIs), Generic pharmaceuticals, Skin care products. |
Total No. of Employees | 5,001–10,000 |
Managing Director | Prashant Tewari, Leena Tewari Gandhi, Nikhil Trivedi. |
Contact them – Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai – 400 088. India.
3. Serdia Pharmaceuticals (India) Pvt. Ltd.:
Serdia Pharmaceuticals (India) Pvt. Ltd. has been in existence in India since 1986. The company is well-respected in the medical fraternity for its original products, strong scientific base, and ethical promotion. They also provide services to the medical profession through the introduction of innovative molecules, information-based medical visits, and the organization of reputed scientific meetings. Their corporate office, situated at a prime location in Mumbai, is well-equipped with modern amenities.
The corporate office houses excellent teams for product promotion comprising doctors and pharmacists, as well as a well-equipped training department providing training on scientific knowledge and management across a wide spectrum of topics. Serdia Pharmaceuticals is one of India’s leading and Topmost MNC Pharma Companies. Their offered product list includes:
- Coralan 5mg
- Coversyl 2mg
- Coversyl 4mg
- Natrilix
- Natrilix SR
- Natrilam 2.5
- Diamicron
- Diamicron MR
- Daflon 1000mg
- Daflon 500mg
- Stablon
- Trivastal L.A. ETC.
Established Year | 1986 |
GST No. | 25AAACS6696R1ZF |
Drug License | Yes |
Product Range | NA |
Major Categories | Anti-hypertension and metabolism. |
Total No. of Employees | 51–200 |
Managing Director | Yanick Martial Girard, Pierre Jean Bernard Andriot, Philippe Louis Marc Malet, Georges Jabre, Geeta Mahadeo Karnik. |
Contact them – Serdia House, Off Dr. S S Rao Road, Behind M G Hospital Parel, Mumbai 400012\
4. AMN Life:
AMN Life is focused on increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals. The company’s line of generic and specialty treatments is backed by our impressive development and manufacturing capabilities, ensuring the highest quality and accessibility to medicines while reducing costs.
They take pride in producing quality generic pharmaceuticals, consistently meeting and exceeding industry and global regulatory standards. The company strives for excellence in everything we do, from sourcing to formulation and marketing. With the objective of building a sustainable business, they have been continuously filing products for registration in different countries of emerging markets, across therapeutic segments. Their offered product list includes:
- Albendazole 400mg Tablets
- Esomeprazole Magnesium Trihydrate 20mg/40mg Tablets
- Lansoprazole 30mg Delayed-Release Capsules U.S.P.
- Metronidazole 400mg + Diloxanide Furoate 500mg F.C.Tablets
- Rabeprazole Sodium enteric coated 10/20mg Tablets
- Esomeprazole 20mg + Domperidone 10mg Caps
- Psyllium Husk (Each teaspoonful 5.8gms contains Psyllium Husk 3.8gms)
- Omeprazole 40mg injections-Lyophilised
- Ondansetron 2mg/ml – 2ml & 4ml injections
- Ranitidine injections 50mg/2ml in 2ml amp etc.
Established Year | 2003 |
GST No. | 02AAECA4007A1ZR |
Drug License | Yes |
Product Range | 300 |
Major Categories | Antibiotics, Anti-Diabetic, Cardiology, Nephrology, & General Health segments. |
Total No. of Employees | 101 – 250 |
Managing Director | Ashish Vijay Khemka and Reshma Ashish Khemka. |
Address – 811, A-Wing, The Capital, Bandra-Kurla Complex, Bandra (East) – 400 051. Mumbai – INDIA.
5. Harson Laboratories:
Their organization established in 1970 is headed by an expert team that envisaged marketing strategy by experienced business vision. A reflection of the extent of Harson’s expertise is the wide range of products that are presently being marketed domestically as well as internationally with great success. Product Innovation is the keystone to a company’s progress and Harson is particularly well placed to take advantage of new product opportunities.
They have very sophisticated plants and types of machinery to manufacture high-quality products. The company is following up with stringent quality control and Good Manufacturing Practices as per World Health Organization standards. They have also our own empty ampoule manufacturing plant. The company is one of the leading MNC Pharma Companies in India. Their offered product list includes:
- ADRENALINE INJECTION BP
- AMIKACIN SULPHATE INJECTION BP
- AMINOPHYLLINE INJECTION BP
- ATRACURIUM BESYLATE INJECTION USP
- BUPIVACAINE IN DEXTROSE INJECTION USP
- CALCIUM GLUCONATE AND CALCIUM LACTOBIONATE INJECTION
- HYOSCINE BUTYL BROMIDE INJECTION BP
- MENAPHTHONE SODIUM BISULPHITE INJECTION
- PANCURONIUM INJECTION BP
- PENTAZOCINE LACTATE INJECTION BP
- QUININE DIHYDROCHLORIDE INJECTION
- SODIUM CHLORIDE INTRAVENOUS INFUSION BP
- STERILE POTASSIUM CHLORIDE CONCENTRATE BP
- TRANEXAMIC ACID INJECTION BP
- VITAMINS B1,B6,B12 & D-PANTHENOL INJECTION
Established Year | 1970 |
GST No. | 24AABFH0395N1Z9 |
Drug License | Yes |
Product Range | NA |
Major Categories | Injections, Other products: Lincomycin injection. |
Total No. of Employees | 11-50 |
Managing Director | Jayesh Chandulal Vora. |
Contact them – 12, R. C. Patel Industrial Estate, Akota, Baroda – 390 020. INDIA
6. Tuttsan Pharma Pvt. Ltd.:
Tuttsan Pharma Pvt. Ltd. is an ISO 9001:2008 certified Company involved in the production of a wide range of products covering all areas of disease and forms. The company was Established by the dedicated efforts put in by a team of committed professionals with a strong determination to serve Humanity. They strive to become one of the knowledge-driven MNC pharma companies with the highest level of operational excellence in all spheres of life. Their core endeavors are to add value to customers and maximize the strength of customer relationships.
Tuttsan Pharma aims to deliver research-based pharmaceutical products to its esteemed clients. They have been providing affordable medicines that are of high quality. Quality is their biggest strength and they have an in-house manufacturing unit to manufacture high-quality products at par with international standards. Tuttsan Pharma Pvt. Ltd. operates in domestic as well as export markets. More than 75% of total production is exported. Their offered product list includes:
- TULEV-250 TAB (Alu-Alu)
- OLACEF TAB (Alu-Alu)
- OLAFSUN OZ Susp
- OLACEF DRY SYP
- CEFSAN 100DT TAB (Alu-Alu)
- ZITHSAN-250 TAB
- TUJOY-100 DT TAB (Alu-Alu)
- TUJOY CV-325 TAB (Alu-Alu)
- TURCEF 250 TAB (Alu-Alu)
- TUCLAV DRY SYRUP
- SANPRO-B CAP (Alu-Alu) DRUG
- CEFSAN-OZ TAB (Alu-Alu)
- SAMOX-250 TAB
- TUJOY-CV DRY SYP
- OLAFSUN-200 TAB (Alu-Alu) etc.
Established Year | 2004 |
GST No. | 24AACCT0336M1ZF |
Drug License | Yes |
Product Range | 350 |
Major Categories | Tablets, Capsules, Softgels, Injectables, Syrups, Drops, Ointments, Creams, Gels, and Protein powders. |
Total No. of Employees | 61 |
Managing Director | TUSHAR RASTOGI, SHIVANSHU GOPAL RASTOGI. |
Contact them – Tuttsan House, Block No. 196-228, National Highway No. 8-A Near Mukteshwar Mahadev Temple, Village Navapura, Taluka Sanand, Sarkhej-Changodar Road, Ahmedabad-382210, Gujarat
7. Wockhardt:
Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, and a chain of advanced Super Speciality Hospitals. Wockhardt is a true Indian MNC pharma company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally.
It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations to active Pharmaceutical Ingredients (APIs) and Vaccines. Headquartered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland, and France. Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions of people’s lives through better health. Their offered product list:
- Ace Proxyvon
- Aceroc
- Alphadopa
- B.G.Prot
- Biovac Flu
- Biovac Typhoid
- B-Lift Active Lifting Gel
- B-Lift Rich Lifting Gel
- Bond-7
- Bio-Corneum
- B-Lift Eye Contour
- Biovac-B
- Biovac-A
- Bio-Corneum
Established Year | 1967 |
GST No. | 03AAACW2472M1Z9 |
Drug License | Yes |
Product Range | NA |
Major Categories | Medicines, Nutrition products, Vaccines, Active pharmaceutical ingredients (APIs), Skin care, Baby care. |
Total No. of Employees | 3,000 |
Managing Director | Ms. Zahabiya Khorakiwala. |
Contact them – Wockhardt Towers Bandra Kurla Complex, Bandra (East) Mumbai 400051 Maharashtra, India
8. Marksans Pharma Ltd.:
Marksans Pharma, headquartered in Mumbai (India) is a global pharmaceutical company. They are actively engaged in R&D and offer CRAMS to global MNC pharma companies. The company has established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices, and adhering to stringent regulatory compliances. Their plants are approved by the prestigious US FDA, UK MHRA, Australian TGA, and other foreign health authorities. The company is one of the leading MNC Pharma Companies in India.
Their R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development, and conducting stability studies. They have a team of over 50 experienced scientists specializing in formulation development and analytical development. The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.
Their dedicated research team is committed to developing a range of formulations and products as per customer specifications and to positively impact health and well-being.
Established Year | 1992 |
GST No. | 30AAACT3153G1ZW. |
Drug License | Yes |
Product Range | 550 |
Major Categories | Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology. |
Total No. of Employees | 2,000 |
Managing Director | Mr. Mark Saldanha, Mrs. Sandra Saldanha, Mr. Varddhman V. Jain, Mr. Seetharama R. |
Contact them – 11th Floor Grandeur, Off Veera Desai Road, Opp Gundecha Symphony, Andheri (W), Mumbai 400 053.
9. Divi’s Laboratories:
Established in the year 1990. Divi’s is one of the leading MNC pharma companies involves in the manufacturing of Active Pharmaceutical Ingredients offering high-quality products to over 95 countries. Divi manufactures Generic APIs and nutraceutical Ingredients and offers Custom Synthesis of APIs to Big Pharma providing a competitive advantage over the entire life cycle of the products. The company believes in meeting or exceeding the quality levels set by the customer and strives to adhere to stringent global regulatory standards.
The company recently reached the milestone of being one of the top 3 API manufacturers in the world and one of the top API companies in Hyderabad. 11,000 highly trained professionals across departments and 350 scientists at Divi’s work together to bring world-class products to customers. Advanced manufacturing facilities both in Hyderabad and Vizag have been inspected multiple times by the FDA, EU GMP (UK, Slovenia, German, and Irish authorities), HEALTH CANADA, TGA, ANVISA, COFEPRIS, PMDA, and MFDS health authorities.
The product list includes:
- Capecitabine
- Diltiazem HCl
- Dextromethorphan Base
- Dextromethorphan HBr
- Fosphenytoin Sodium
- Gabapentin
- Levetiracetam
- Olmesartan medoxomil
- Proguanil HCl
- Quetiapine Fumarate
- Venlafaxine HCl
- Beta Carotene
- Astaxanthin
- Lycopene etc.
Established Year | 1990 |
GST No. | 36AAACD6745J1ZH |
Drug License | Yes |
Product Range | NA |
Major Categories | Active pharmaceutical ingredients (APIs), Nutraceuticals, Intermediates, Peptides, Carotenoids, Vitamin D3 and vitamin A. |
Total No. of Employees | 17,000 |
Managing Director | Dr. S. Devendra Rao. |
Contact them – Chippada Village, Annavaram Post, Bheemunipatnam Mandal, Visakhapatnam Dist, Andhra Pradesh – 531 162.
10. Sanofi India Limited:
Sanofi India Limited is one of the entities through which Sanofi operates in India. It was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Sanofi, one of the world’s leading healthcare companies, and its 100% subsidiary – Hoechst GmbH are the major shareholders of Sanofi India Limited and together hold 60.4% of its paid-up share capital. The company has two manufacturing sites in Ankleshwar and Goa. Sanofi India Limited also manufactures its products. The company is one of the leading MNC Pharma Companies in India.
These sites manufacture products with stringent global quality guidelines, also approved by regulatory agencies such as
- Medicines and Healthcare Products Regulatory Agency (MHRA) from the United Kingdom,
- Regierungspräsidium Darmstadt from Germany
- Medicines Control Council (MCC) from South Africa
- Taiwan Food & Drug Administration (TFDA) from Taiwan
- State Administration of Ukraine on Medicinal Products (SAUMP) from Ukraine
- and Pharmacy & Poisons Board (PPB) from Kenya. The product list includes:
Their Product list includes following
- Adenocor®
- Amaryl® MP
- Amaryl® M Forte
- Brodactam™
- Cardace® Protect
- Amaryl® MV
- Cardace® Meto
- Cetapin® XR
- Cordarone® / Cordarone® X
- Depakote® XR
- Insuman® Comb 25
- Semi-Amaryl® /Amaryl®
- Lasilactone® 50
- Vinlep™ Suspension
Established Year | 1956 |
GST No. | 03AAACH2736F1Z4 |
Drug License | Yes |
Product Range | 295 |
Major Categories | Prescription medicines, Vaccines, Consumer healthcare products, Specialty care products. |
Total No. of Employees | 3,000 |
Managing Director | Aditya Narayan, Rodolfo Hrosz, Usha ThoratRahul Bhatnagar. |
Contact them – Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072 (022) 28032000
11. Orchid Chemicals & Pharmaceuticals Ltd.:
Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing, and marketing. Their pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, new drug discovery (NDD), novel drug delivery systems (NDDS), and contract research and manufacturing services (CRAMS).
They today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. They are globally present across 70+ countries through alliances, joint ventures, and partnerships with globally reputed majors. Their integrated business model enables them to cater to business opportunities throughout the value chain, from research to delivery of drugs.
The product list includes:
- S (-) Amlodipine Besilate and Atenolol Tablets
- Indapamide tablets USP
- Indapamide with Atenolol tablets
- Losartan potassium tablets
- Losartan potassium with hydrochlorothiazide tablets
- Metoprolol Succinate Extended-Release Tablets USP
- Metoprolol ER with Hydrochlorothiazide Tablets
- Olmesartan Medoxomil and Hydrochlorothiazide tablets
- Propranolol HCl sustained-release capsules USP
- Amlodipine Besilate and Atenolol Tablets
- Ramipril and Hydrochlorothiazide Tablets
- Telmisartan and Hydrochlorothiazide Tablets
Established Year | 1992 |
GST No. | 33AAACO0402B1ZJ |
Drug License | Yes |
Product Range | NA |
Major Categories | Tablets, syrups, and injections. |
Total No. of Employees | 4,000 |
Managing Director | Manish Dhanuka, Arjun Dhanuka, Dharam Vir, Shubha Singh. |
Contact them – #313, Valluvar Kottam High Road Nungambakkam Chennai – 600 034 Tamil Nadu, India
12. Franco Indian Pharmaceuticals Pvt Ltd:
As one of the most reputed pharmaceutical companies in the country, Franco-Indian Pharmaceuticals Pvt. Ltd. (FIPPL), founded in 1949, understands the importance of making safe and quality medications accessible and affordable to help people lead longer and healthier lives. Headquartered in Mumbai, the FIPPL team has nearly 2000 employees, which includes a Marketing team of nearly 1200 personnel, with 23 C&F Agents and nearly 1600 Distributors. The company is one of the leading MNC Pharma Companies in India.
FIPPL is over 400 crore turnover company that manufactures and markets an impressive portfolio of products, even as it has developed productive alliances and partnerships to create innovative medicines at nominal costs through world-class research and development efforts. FIPPL also has a vibrant global presence and exports its formulations to Asia and Africa, through its own distribution network, besides reaching out to the markets in the UK, France, and the USA. The product list they manufacture includes:
- GRILINCTUS–BM® Paediatric Syrup
- RELAXYL DA THERMOGEL®
- EVACUOL® Granules
- DEXORANGE® Paediatric Syrup
- AMICLINE PLUS® Tablets
- MONLEVO JUNIOR® Tablets
- OMILCAL FORTE® Tablets
- ZINDEE® Sachet / ZINDEE® Chewable Tablets
- SURFAZ-O® Tablets
- GRILINCTUS–BM® Syrup/Tablets
- SURFAZ-SN® Cream
- SURFAZ® Cream/Solution/Powder etc.
Established Year | 1949 |
GST No. | 07AAACF1794M1ZB |
Drug License | Yes |
Product Range | NA |
Major Categories | Hematinics, Anti-diabetics, Cough preparations, Digestive and liver disorders, Dermatologicals, and Other products. |
Total No. of Employees | 2000 |
Managing Director | Errol J De Souza, Jagdish PurushottAMDAS Mehta, Lalsa Balgovind Yadav, Noel Christopher Ammanna, Debranjan Sinha, Pascal Postel. |
Contact them – 20, Dr. E. Moses Road Mahalaxmi Mumbai – 400 011
13. Ethypharm India:
They are a European-based specialty pharmaceutical company with global reach and a committed player in the treatment of pain, addiction, and critical care. The company also develops and markets specialty drugs and generics that provide added value to healthcare providers and deliver high-quality medicines for patients. They make available to patients around the globe, their world-class portfolio of drugs to treat pain, addiction, and critical care.
Their starting point is always: how they can meet an unmet medical need and make a difference for patients.
Their facilities are of the highest standards of quality and have been approved by multiple regulatory authorities around the world. The company is able to manufacture in-house oral solid doses, liquid forms, injectables, and pre-filled syringes. Their aim is to ensure access to our medicines, in the best conditions of safety and efficacy possible. The company is one of India’s leading and reputed MNC Pharma Companies. The product list they manufacture includes:
- Morphine® sulfate prolonged-release or immediate-release
- Morphine® Oral Solution
- Fentanyl®
- Tramadol®
- Oxycodone odt®
- Oxycodone hydrochloride®
- Etodolac – Lodine®
- Triamcinolone Hexacetonide– Hexatrione® etc.
Established Year | 1997 |
GST No. | 30AAACE4532G1ZA |
Drug License | Yes |
Product Range | NA |
Major Categories | Specific Central Nervous System (CNS) diseases and conditions. |
Total No. of Employees | 1,001-5,000 |
Managing Director | Conrad M C Menezes and Maria Ana Paula Menezes. |
Contact them – Fortune 2000 C1, 2nd Floor, Bandra Kurla Complex-Bandra East, Mumbai – 400051
Recent Growth and Statistics about MNC Pharma Companies in India
- Pharma MNCs are riding on innovation and are operating in niche therapies. MNC pharma companies focus on a few brand products and enjoy premium pricing on these products as they are restricted to the top end of the market.
- They also are 100% focused on the Indian market where there is less regulatory risk and on growing fewer premium brands in the domestic market. As per data culled from the AIOCD-AWACS, the market research wing of the All India Organisation of Chemists and Druggists (AIOCD). The association represents over 500,000 medicines sellers across India, in terms of growth in moving annual turnover (MAT) value, while the IPM clocked an 11.4 percent growth.
Conclusion:
Pharmaceuticals, India’s emerging industry, has appeared as the world leader in the fabrication of standard generic drugs, ever since the Patent Act of 1970 permitted India to seriously approach and contribute to the pharmaceutical market worldwide. The workforce and technological proficiency of pharmaceutical companies in India ensure the growth of the industry on a global scale as well as within India.
These are the best List of MNC Pharma Companies in India and if you are looking forward to starting a PCD pharma business then you can opt for any company within the list to attain a good profit in your business. We believe that the information in this report is useful for you. So go ahead and choose any of the listed MNC Pharma Companies in India. For more, you can also visit our official website. You can also fill out the contact form or call us. We always seek the opportunity to help you.
FAQs For Top 13 MNC Pharma Companies in India –
Q1. What are the major categories of products offered by MNC Pharma Companies in India?
Ans. The major categories include derma products, pharmaceutical tablets, capsules, liquids, drops, and creams or ointments.
Q2. Are these companies engaged in research and development (R&D)?
Ans. Yes, many of these MNC pharma companies in India have dedicated research and development teams focused on finding innovative therapies and developing new pharmaceutical products.
Q3. What certifications and standards do these companies adhere to?
Ans. These MNC pharma companies often hold certifications such as WHO-GMP, ISO, and other industry-specific standards to ensure the quality and safety of their products.

Hi, I am Aditi. I have a Degree in M.SC. Biotech. I love to write content related to the Pharmaceutical industry. I have been writing content related to the pharmaceutical industry for the past 5 years. I also have a work experience of more than 3 years as a research scientist. Linkedin Profile